Magrey, M., Marzo-Ortega, H., Kadono, Y., Nicholls, D., Rudwaleit, M., Deodhar, A., Varkas, G., et al. (2025). Bimekizumab was Efficacious Regardless of Age, BMI, CRP, or HLA-B27 Status: 1-Year Results from Two Phase 3 Studies.
Abstract Supplement ACR Convergence 2025, October 24–29, 2025 Chicago, IL, Arthritis & Rheumatology,
77, 2825-2829. Hoboken: Wiley.
https://doi.org/10.1002/art.43421